[Comment] Oral JAK inhibitors for vitiligo: a new era of innovation | ClinicLens
Non-segmental vitiligo, a chronic immune-mediated depigmenting skin condition affecting millions of individuals worldwide, has long occupied a paradoxical position within dermatology.1 Despite its considerable impact on patients’ wellbeing and quality of life, it has historically
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.